|
POLE2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
8.003200E-04 |
| Normal-vs-Stage3 |
8.86100000041523E-08 |
| Normal-vs-Stage4 |
4.247800E-02 |
| Stage1-vs-Stage2 |
2.438200E-01 |
| Stage1-vs-Stage3 |
3.916900E-03 |
| Stage1-vs-Stage4 |
4.731400E-01 |
| Stage2-vs-Stage3 |
3.443300E-03 |
| Stage2-vs-Stage4 |
2.767400E-01 |
| Stage3-vs-Stage4 |
8.066400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.08270084406581E-11 |
| Normal-vs-Asian |
5.758000E-03 |
| Caucasian-vs-AfricanAmerican |
4.815000E-01 |
| Caucasian-vs-Asian |
2.969200E-01 |
| AfricanAmerican-vs-Asian |
1.211220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.17809983990469E-10 |
| Male-vs-Female |
7.778300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.27020000073585E-08 |
| Normal-vs-Extreme_Weight |
1.77635683940025E-15 |
| Normal-vs-Obese |
1.26900000507746E-08 |
| Normal-vs-Extreme_Obese |
4.890100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.785200E-01 |
| Normal_Weight-vs-Obese |
3.374000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.895620E-01 |
| Extreme_Weight-vs-Obese |
1.304030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.893230E-01 |
| Obese-vs-Extreme_Obese |
4.786300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.064700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.119790E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.832410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.262100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.236200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.231600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.230000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.408410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
6.7918000001832E-08 |
| Normal-VS-KIRP CIMP |
1.364480E-02 |
| Normal-VS-Unclassified PRCC |
3.90650000015036E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.505820E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.026400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.061200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.730400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.712410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.986000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00659999955089E-07 |
| Normal-vs-N1 |
4.11690000000631E-05 |
| Normal-vs-N2 |
3.895800E-01 |
| N0-vs-N1 |
1.260480E-02 |
| N0-vs-N2 |
4.338400E-01 |
| N1-vs-N2 |
1.294570E-01 |
|
|
